Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2690037 | Clinical Nutrition | 2006 | 9 Pages |
Abstract
These results demonstrate the infusion of u-AIOs with starting PFAT5 levels of approximately 0.1% show evidence of pathological consequences to the liver and lungs, and therefore, such unstable AIO mixtures should probably be avoided in the clinical setting.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
David F. Driscoll, Pei-Ra Ling, Bruce R. Bistrian,